Multiple Courses of Indomethacin and Neonatal Outcomes in Premature Infants
Authors:
- 18 December 2007
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 29 (5) , 878-884
Abstract
The objective of this retrospective cohort study was to determine patent ductus arteriosus (PDA) closure rate with multiple short courses (three doses) of postnatal indomethacin and compare neonatal outcomes in infants who received two versus three courses of indomethacin for PDA closure. Infants <34 weeks’ gestational age born between January 2000 and December 2004 at the University of Maryland Medical Center and who received two or more short courses of indomethacin were included. Outcome measures were ductal closure rate and neonatal outcomes. Of 61 infants who were identified to have received two or more courses of indomethacin, 26 infants closed their ductus after the second course (response rate, 42%). Of the 35 infants who failed ductal closure after two courses, 11 infants had their ductus ligated and 23 received a third course of indomethacin. Of 23 who received a third course, 10 closed their ductus (response rate, 43%). There was no significant difference in the incidence of chronic lung disease, severe retinopathy of prematurity, necrotizing enterocolitis, renal function, or mortality between infants who received two and those who received three courses of indomethacin. Infants exposed to three courses of indomethacin had a statistically nonsignificant increased incidence of periventricular leukomalacia (p = 0.08; adjusted odds ratio = 4.8; 95% CI, 0.8–30) and remained in the hospital for a longer duration (p = 0.02) compared to infants exposed to two courses of indomethacin. We conclude that multiple courses of indomethacin may be associated with a ductal closure. However, the requirement for a third course may be associated with an increased risk of periventricular leukomalacia.Keywords
This publication has 31 references indexed in Scilit:
- Patent Ductus Arteriosus: Evidence for and against TreatmentThe Journal of Pediatrics, 2007
- Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacinThe Journal of Pediatrics, 2003
- Current treatment strategies of symptomatic patent ductus arteriosusJournal of Pediatric Health Care, 2002
- Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants2001
- Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.Archives of Disease in Childhood, 1992
- The Pharmacological Treatment of Patent Ductus ArteriosusDrugs, 1989
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Pharmacokinetics of intravenously administered indomethacin in premature infantsThe Journal of Pediatrics, 1980
- The disposition of indomethacin in preterm babiesThe Journal of Pediatrics, 1980
- Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infantsThe Journal of Pediatrics, 1978